Erratum Regarding "US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States" (Am J Kidney Dis. 2018;71[3][suppl 1]:Svii,S1-S676).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. The effect of intradialytic combined exercise on hemodialysis efficiency in end-stage renal disease patients: a randomized-controlled trial.International urology and nephrology · 2020
   Trial
2. Nomenclature for kidney function and disease: executive summary from a KDIGO consensus conference.Nature reviews. Nephrology · 2020
   Article
3. AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice.Scientific reports · 2019
   Article

Corrections and comments

• Erratum for
  US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.2018

Authors and funding

0 authors.

Funding

Abstract

PubMed holds no abstract for this paper.